Skip to content

Drug interactions

Aprepitant + Lemborexant

Severity: Major

Aprepitant and Lemborexant: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Aprepitant can raise lemborexant exposure through CYP3A4 inhibition. This may cause excess somnolence, next-day impairment and impaired driving ability.

What this interaction means in plain words

Aprepitant and Lemborexant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Aprepitant belongs to Gastrointestinal Tract; Lemborexant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Aprepitant inhibits CYP3A4, reducing lemborexant clearance.

What to do

Avoid combining where possible as labeling advises against moderate CYP3A inhibitors. If unavoidable, use the lowest lemborexant dose (5 mg) and counsel about next-day sedation.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Lemborexant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Lemborexant?

MediHelp rates the interaction as major. Aprepitant and Lemborexant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Aprepitant can raise lemborexant exposure through CYP3A4 inhibition. This may cause excess somnolence, next-day impairment and impaired driving ability.

How serious is the interaction between Aprepitant and Lemborexant?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible as labeling advises against moderate CYP3A inhibitors. If unavoidable, use the lowest lemborexant dose (5 mg) and counsel about next-day sedation.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in